Has Jian Chu received payments from drug or device companies?

Yes. Drug and device makers reported $7,301 in general payments to Jian Chu across 77 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Jian Chu did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Jian Chu come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Jian Chu

Internal Medicine · Oklahoma City, OKNPI 1023630860

Payments from drug & device makers

$7,301in general payments, 2019–2025

Across 77 payments — averaging $94.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Abbott$2K
Abiomed$1K
Medtronic$1K
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$659
Stryker$320
Alnylam Pharmaceuticals Inc.$267
plus $1K from 12 others

$28in research payments, 2019–2025

Across 1 payment — averaging $27.87 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Abiomed$28

What the payments were for

Travel & lodging$1,81825%
Food & beverage$5,22772%
Education$2564%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Abbott	18	$2,254
Abiomed	12	$1,276
Medtronic	6	$1,059
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)	12	$659
Stryker	3	$320
Alnylam Pharmaceuticals Inc.	2	$267
Boston Scientific	3	$259
Pfizer	2	$208
Novartis	2	$181
Kestra Medical Technology Services, Inc.	1	$145
Shockwave Medical, Inc	1	$132
Chiesi USA, Inc.	1	$112
Impulse Dynamics (USA) Inc.	2	$103
Teleflex LLC	1	$84
Inari Medical, Inc.	4	$77
Edwards Lifesciences	3	$62
E.r. Squibb & Sons, L.L.C.	2	$53
Cardiva Medical, Inc.	2	$50

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,301 in reported general payments places this provider in the 90th percentile of 840 internal medicine providers in Oklahoma.

See all internal medicine providers in Oklahoma →

Other internal medicine in Oklahoma City

Sagila GeorgeOklahoma City$1.8M
Ryan MorganOklahoma City$775K
Samid FarooquiOklahoma City$129K
Minh PhanOklahoma City$77K
Ali JafryOklahoma City$33K
Stuart SchraderOklahoma City$29K
Dale BratzlerOklahoma City$17K
Karen ChopraOklahoma City$16K
Charlsie RecordOklahoma City$14K
Jeannette KelleyOklahoma City$14K

See the full list for Oklahoma →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →